Kestra Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Kestra Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.5M	Buy	239,312 +42,995	+22%	+$2.51M	0.05%	350
2025 Q4	$10.6M	Buy	196,317 +1,484	+0.8%	+$71.4K	0.04%	406
2025 Q3	$8.79M	Sell	194,833 -12,102	-6%	-$565K	0.04%	440
2025 Q2	$9.58M	Sell	206,935 -12,823	-6%	-$629K	0.05%	390
2025 Q1	$13.4M	Sell	219,758 -13,511	-6%	-$788K	0.06%	274
2024 Q4	$13.2M	Sell	233,269 -32,179	-12%	-$1.8M	0.07%	281
2024 Q3	$13.7M	Sell	265,448 -23,927	-8%	-$1.12M	0.08%	282
2024 Q2	$12M	Buy	289,375 +67,883	+31%	+$3.04M	0.07%	312
2024 Q1	$12M	Buy	221,492 +30,297	+16%	+$1.54M	0.08%	262
2023 Q4	$9.81M	Sell	191,195 -286	-0.1%	-$15K	0.08%	281
2023 Q3	$11.1M	Sell	191,481 -41,484	-18%	-$2.54M	0.11%	213
2023 Q2	$14.9M	Buy	232,965 +64,536	+38%	+$4.33M	0.15%	148
2023 Q1	$11.7M	Sell	168,429 -51,025	-23%	-$3.6M	0.13%	181
2022 Q4	$15.8M	Sell	219,454 -30,043	-12%	-$2.27M	0.14%	171
2022 Q3	$17.7M	Buy	249,497 +64,203	+35%	+$4.66M	0.19%	123
2022 Q2	$14.3M	Buy	185,294 +31,198	+20%	+$2.38M	0.15%	150
2022 Q1	$11.3M	Sell	154,096 -63,570	-29%	-$4.27M	0.12%	196
2021 Q4	$13.6M	Sell	217,666 -44,107	-17%	-$2.59M	0.14%	171
2021 Q3	$15.5M	Buy	261,773 +50,685	+24%	+$3.34M	0.15%	151
2021 Q2	$14.1M	Buy	211,088 +6,851	+3%	+$447K	0.16%	147
2021 Q1	$12.9M	Sell	204,237 -55,665	-21%	-$3.46M	0.16%	147
2020 Q4	$16.1M	Buy	259,902 +85,563	+49%	+$5.26M	0.19%	122
2020 Q3	$10.6M	Buy	+174,339	New	+$10.5M	0.2%	135

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kestra Advisory Services's BMY Position: Q1 2026 in Review

Kestra Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, buying an estimated $2.51M and bringing the position to 239,312 shares worth $14.5M. The position accounts for 0.05% of the portfolio, ranked #350.

Kestra Advisory Services first reported a position in BMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $17.7M in Q3 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Kestra Advisory Services held 239,312 shares of Bristol-Myers Squibb worth $14.5M as of Q1 2026.
Kestra Advisory Services bought 42,995 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.51M.
Bristol-Myers Squibb made up 0.05% of Kestra Advisory Services's portfolio in Q1 2026, its #350 holding.
Kestra Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 23 quarters since.
Kestra Advisory Services's Bristol-Myers Squibb position peaked at $17.7M in Q3 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.